Inhibition of Casein Kinase II by CX-4945, But Not Yes-associated protein (YAP) by Verteporfin, Enhances the Antitumor Efficacy of Temozolomide in Glioblastoma

Overcoming temozolomide (TMZ) resistance in glioma cancer cells remains a major challenge to the effective treatment of the disease. Increasing TMZ efficacy for patients with glioblastoma (GBM) is urgently needed because TMZ treatment is the standard chemotherapy protocol for adult patients with gli...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiangyu, Chen, Jieyu, Li, Wei, Hang, Chunhua, Dai, Yuyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909086/
https://www.ncbi.nlm.nih.gov/pubmed/31810002
http://dx.doi.org/10.1016/j.tranon.2019.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909086/
https://www.ncbi.nlm.nih.gov/pubmed/31810002
http://dx.doi.org/10.1016/j.tranon.2019.09.006

Ejemplares similares